The BIOSECURE Act was passed with a large bipartisan majority in the House in 2024 and now awaits action in the Senate in 2025. Passage of the Act would be a significant first step in protecting ...
At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...
A Chinese pharmaceutical company expects to hire up to 500 employees for the first phase of its new campus in northern ...
It is now apparent that nearly every Trump appointee is a diehard anti-China high priest or priestess. That’s not just Marco ...
Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.
Pharma Sector Multibagger Opportunity - Explore how India could win big in the CDMO space with China-Plus-One strategy, ...
$510,000 of ACADIA PHARMACEUTICALS lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Implementation of the Inflation ...
The deal follows a $1.06 billion U.S. contract in July 2024 and a $1.24 billion agreement with an Asia-based pharma a few ...
US passed Biosecure Act which would ban federal contracts with targeted firms and their business partners. Legislation ...
The US House of Representatives passed the Biosecure Act in September, which would ban federal contracts with targeted firms and their business partners. The legislation, which explicitly names ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback